Prelude Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-196,905
| Closed | -$7.42M | – | 1837 |
|
|
2021
Q1 | $7.42M | Buy |
+196,905
| New | +$7.42M | 0.19% | 27 |
|
|
2019
Q3 | – | Sell |
-400
| Closed | -$2K | – | 1756 |
|
|
2019
Q2 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 1177 |
|
|
2018
Q4 | – | Sell |
-906
| Closed | -$13K | – | 1879 |
|
|
2018
Q3 | $13K | Sell |
906
-1,208
| -57% | -$17.3K | ﹤0.01% | 1060 |
|
|
2018
Q2 | $33K | Buy |
2,114
+1,946
| +1,158% | +$30.4K | ﹤0.01% | 989 |
|
|
2018
Q1 | $3K | Buy |
168
+29
| +21% | +$518 | ﹤0.01% | 1289 |
|
|
2017
Q4 | $3K | Sell |
139
-46
| -25% | -$993 | ﹤0.01% | 1159 |
|
|
2017
Q3 | $8K | Sell |
185
-9,330
| -98% | -$403K | ﹤0.01% | 1332 |
|
|
2017
Q2 | $286K | Buy |
9,515
+3,476
| +58% | +$104K | 0.03% | 421 |
|
|
2017
Q1 | $218K | Buy |
6,039
+4,939
| +449% | +$178K | 0.02% | 495 |
|
|
2016
Q4 | $55K | Sell |
1,100
-263
| -19% | -$13.2K | 0.01% | 975 |
|
|
2016
Q3 | $72K | Sell |
1,363
-1,137
| -45% | -$60.1K | 0.01% | 867 |
|
|
2016
Q2 | $103K | Buy |
2,500
+700
| +39% | +$28.8K | 0.01% | 707 |
|
|
2016
Q1 | $73K | Buy |
+1,800
| New | +$73K | 0.01% | 791 |
|
|
2015
Q3 | – | Sell |
-2,500
| Closed | -$62K | – | 1819 |
|
|
2015
Q2 | $62K | Buy |
2,500
+300
| +14% | +$7.44K | 0.01% | 1003 |
|
|
2015
Q1 | $50K | Buy |
+2,200
| New | +$50K | 0.01% | 1231 |
|
|
2014
Q4 | – | Sell |
-3,100
| Closed | -$36K | – | 2122 |
|
|
2014
Q3 | $36K | Buy |
+3,100
| New | +$36K | 0.01% | 1427 |
|